|
|
|
|
| LEADER |
01000naa a22002652 4500 |
| 001 |
NLM177561122 |
| 003 |
DE-627 |
| 005 |
20231223150455.0 |
| 007 |
tu |
| 008 |
231223s2008 xx ||||| 00| ||eng c |
| 028 |
5 |
2 |
|a pubmed24n0592.xml
|
| 035 |
|
|
|a (DE-627)NLM177561122
|
| 035 |
|
|
|a (NLM)18268805
|
| 040 |
|
|
|a DE-627
|b ger
|c DE-627
|e rakwb
|
| 041 |
|
|
|a eng
|
| 100 |
1 |
|
|a Marino, Mark T
|e verfasserin
|4 aut
|
| 245 |
1 |
0 |
|a Drugs that can worsen diabetes control
|
| 264 |
|
1 |
|c 2008
|
| 336 |
|
|
|a Text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a ohne Hilfsmittel zu benutzen
|b n
|2 rdamedia
|
| 338 |
|
|
|a Band
|b nc
|2 rdacarrier
|
| 500 |
|
|
|a Date Completed 25.02.2008
|
| 500 |
|
|
|a Date Revised 19.11.2015
|
| 500 |
|
|
|a published: Print
|
| 500 |
|
|
|a Citation Status MEDLINE
|
| 650 |
|
4 |
|a Journal Article
|
| 650 |
|
7 |
|a Adrenergic beta-Antagonists
|2 NLM
|
| 650 |
|
7 |
|a Antipsychotic Agents
|2 NLM
|
| 650 |
|
7 |
|a Glucocorticoids
|2 NLM
|
| 650 |
|
7 |
|a Sodium Chloride Symporter Inhibitors
|2 NLM
|
| 650 |
|
7 |
|a Niacin
|2 NLM
|
| 650 |
|
7 |
|a 2679MF687A
|2 NLM
|
| 773 |
0 |
8 |
|i Enthalten in
|t Diabetes self-management
|d 1998
|g 25(2008), 1 vom: 12. Jan., Seite 16, 18-20
|w (DE-627)NLM098190385
|x 0741-6253
|7 nnns
|
| 773 |
1 |
8 |
|g volume:25
|g year:2008
|g number:1
|g day:12
|g month:01
|g pages:16, 18-20
|
| 912 |
|
|
|a GBV_USEFLAG_A
|
| 912 |
|
|
|a SYSFLAG_A
|
| 912 |
|
|
|a GBV_NLM
|
| 912 |
|
|
|a GBV_ILN_350
|
| 951 |
|
|
|a AR
|
| 952 |
|
|
|d 25
|j 2008
|e 1
|b 12
|c 01
|h 16, 18-20
|